​

Medicus Pharma Stock (NASDAQ:MDCX)

OwnershipFinancialsChart
Medicus Pharma by TradingView

Previous Close

$2.50

52W Range

$2.41 - $137.00

50D Avg

$8.15

200D Avg

$24.28

Market Cap

$3.60M

Avg Vol (3M)

$106.16K

Beta

-0.61

Div Yield

-

MDCX Company Profile

Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

16

IPO Date

Nov 15, 2024

Website

MDCX Performance

MDCX Financial Summary

Dec 25Dec 24Dec 23
Revenue---
Operating Income$-34.36M$-11.18M$-4.73M
Net Income-$-11.16M$-5.31M
EBITDA$-34.36M$-11.16M$-586.78K
Basic EPS$-2.74$-1.10$-1.53
Diluted EPS$-2.74$-1.10$-1.53

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
TELOTelomir Pharmaceuticals, Inc. Common Stock
ALGSAligos Therapeutics, Inc.
KPTIKaryopharm Therapeutics Inc.
IPSCCentury Therapeutics, Inc.
CUECue Biopharma, Inc.
INMBINmune Bio, Inc.
SKYESkye Bioscience, Inc.